PharmaCyte Biotech Inc (PMCB)

[joe_techi]

Effective strategies are often based on past experiences. Much like college learning and early work experience culminates in subject matter expertise learned over a successful career. Dr. Von Hoff figured out how to do it in 2004, ten years ago. Dr. Von Hoff's history with pancreatic cancer treatments include:
-Gemcitabine (Gemzar) with Eli Lily, FDA approved 1996
-Abraxane with Gemcitabine with Celgene, FDA approved Sept 2013
-MM-398 + 5-FU and leucovorin with Merwimack Pharmaceuticals, FDA submission in 2014

Von Hoff knows how to get drugs FDA approved as is proven by his track record.